Malignant Metastatic Melanoma
Also known as: Malignant Melanoma, Metastatic / Metastatic Malignant Melanoma / Malignant melanoma, metastatic (morphologic abnormality) / Metastatic malignant melanoma (disorder)
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB09037 | Pembrolizumab | 0 | Terminated | 1 |
DB05182 | AS1409 | 1 | Completed | 1 |
DB01268 | Sunitinib | 1 / 2 | Terminated | 1 |
DB00853 | Temozolomide | 1 / 2 | Terminated | 2 |
DB00112 | Bevacizumab | 2 | Completed | 1 |
DB00112 | Bevacizumab | 2 | Terminated | 1 |
DB00958 | Carboplatin | 2 | Active Not Recruiting | 1 |
DB00851 | Dacarbazine | 2 | Completed | 2 |
DB00851 | Dacarbazine | 2 | Terminated | 1 |
DB00584 | Enalapril | 2 | Terminated | 1 |
DB12213 | Etaracizumab | 2 | Completed | 1 |
DB04106 | Fotemustine | 2 | Completed | 1 |
DB03366 | Imidazole | 2 | Completed | 1 |
DB06186 | Ipilimumab | 2 | Completed | 2 |
DB01229 | Paclitaxel | 2 | Active Not Recruiting | 1 |
DB01229 | Paclitaxel | 2 | Completed | 1 |
DB09037 | Pembrolizumab | 2 | Active Not Recruiting | 1 |
DB00571 | Propranolol | 2 | Terminated | 1 |
DB05578 | Ramucirumab | 2 | Completed | 1 |
DB00020 | Sargramostim | 2 | Completed | 1 |